Print Page  Close Window
Receive E-mail AlertsE-mail Alerts
Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
01/03/17Alnylam to Webcast Presentation at 35th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 3, 2017-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 9:00 am PT (12:00 pm ET) at The Westin St. Francis in San Francisco. In addition, the company will webcast the Q&A breakout session immediately following its present... 
Printer Friendly Version
01/03/17Alnylam Announces Management Change and Key Promotion
– Company Announces Departure of Chief Business Officer and Promotion of Pushkal Garg, M.D., to Chief Medical Officer – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 3, 2017-- Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, today announced that David-Alexandre "DA" Gros, M.D., Senior Vice President and Chief Business Officer, plans to leave the company for personal reasons. His resignation will be effective... 
Printer Friendly Version

This part of our website contains archived information which should not be considered current and may no longer be accurate.